Prologis (NYSE:PLD – Get Free Report) had its price objective cut by analysts at BTIG Research from $154.00 to $134.00 in a report released on Friday. The brokerage currently has a “buy” rating on the ...

Ginkgo Bioworks Holdings Inc (DNA) stock saw a modest uptick, ending the day at $10.83 which represents a slight increase of $0.63 or 6.18% from the prior close of $10.2. The stock opened at $10.31 ...

Instacart (CART) stock saw a modest uptick, ending the day at $46.58 which represents a slight increase of $1.47 or 3.26% from the prior close of $45.11. The stock opened at $45.45 and touched a low ...

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

BTIG Research began coverage on shares of ImmunityBio (NASDAQ:IBRX – Free Report) in a report released on Friday morning, Marketbeat reports. The firm issued a buy rating and a $6.00 price target on ...

BTIG raised the firm’s price target on AppLovin (APP) to $437 from $432 and keeps a Buy rating on the shares ahead of its Q4 results. The firm ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...

BTIG analyst Thomas Shrader maintained a Buy rating on Alector (ALEC – Research Report) yesterday and set a price target of $5.00. The ...

Here are four ultra-high-yield dividend stocks trading under $15 that investors can buy now and realize some serious passive ...

BTIG analyst Andre Madrid confirmed his Buy rating and $190.00 price target for FTAI Aviation (NASDAQ: FTAI) stock, despite recent accusations of financial misconduct. The company, currently valued at ...

BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...

BTIG raised the firm’s price target on Insulet (PODD) to $300 from $270 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models in select Medical ...